ENHANCED ACTIVITY OF ANTICANCER DRUGS IN MURINE TUMORS BY CO-ADMINISTRATION WITH 3-AMINO-PYRROLIDINE-2,5-DIONE-N-MUSTARD DERIVATIVE

被引：9

作者：

AMBAYE, RY

INDAP, MA

NAIK, SD

机构：

来源：

关键词：

D O I：

10.1007/BF00400966

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：379 / 382

页数：4

共 20 条

[1] CALABRESI P, 1980, GOODMAN GILMANS PHAR, P1249
[2] CAPIZZI RL, 1977, SEMIN ONCOL, V4, P227
[3] CHABNER BA, 1985, CANCER PRINCIPLES PR, V1, P290
[4] DEVITA VT, 1975, CANCER, V35, P98, DOI 10.1002/1097-0142(197501)35:1<98::AID-CNCR2820350115>3.0.CO
[5] 2-B
[6] FREIREICH EMIL J., 1966, CANCER CHEMOTHERAP REP, V50, P219
[7] GERAN RI, 1972, CANC CHEMOTHER REP, V3, P1
[8] GOLDIN A, 1982, CANCER MED, P633
[9] SYNERGISTIC AND ANTAGONISTIC INTERACTIONS OF METHOTREXATE AND 1-BETA-D-ARABINOFURANOSYLCYTOSINE IN HEPATOMA-CELLS - THE MODULATING EFFECT OF PURINES
JACKSON, RC
HARKRADER, RJ
[J]. BIOCHEMICAL PHARMACOLOGY, 1981, 30 (03) : 223 - 229
[10] JACKSON RC, 1987, NATL CANCER I MONOGR, V5, P9